Liangbin Zhou

510 total citations
19 papers, 378 citations indexed

About

Liangbin Zhou is a scholar working on Biomedical Engineering, Rheumatology and Surgery. According to data from OpenAlex, Liangbin Zhou has authored 19 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomedical Engineering, 6 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Liangbin Zhou's work include Osteoarthritis Treatment and Mechanisms (6 papers), 3D Printing in Biomedical Research (5 papers) and Periodontal Regeneration and Treatments (3 papers). Liangbin Zhou is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (6 papers), 3D Printing in Biomedical Research (5 papers) and Periodontal Regeneration and Treatments (3 papers). Liangbin Zhou collaborates with scholars based in Hong Kong, China and Netherlands. Liangbin Zhou's co-authors include Kevin Ki‐Wai Ho, Jiankun Xu, Martin J. Stoddart, Ling Qin, Wenxue Tong, Yuxiao Lai, R. Geoff Richards, Jos Malda, Ziyi Chen and Ye Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Healthcare Materials.

In The Last Decade

Liangbin Zhou

17 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangbin Zhou Hong Kong 7 186 127 94 81 54 19 378
Melika Sarem Germany 13 255 1.4× 90 0.7× 182 1.9× 95 1.2× 99 1.8× 20 545
Hwa‐Chang Liu Taiwan 8 175 0.9× 83 0.7× 132 1.4× 110 1.4× 53 1.0× 14 390
Weikun Meng China 13 141 0.8× 84 0.7× 95 1.0× 153 1.9× 98 1.8× 24 453
Timothy M. Acri United States 12 313 1.7× 67 0.5× 130 1.4× 71 0.9× 90 1.7× 18 499
Xiaoquan Ding China 10 212 1.1× 109 0.9× 116 1.2× 118 1.5× 66 1.2× 14 436
Saeed Farzad‐Mohajeri Iran 14 234 1.3× 54 0.4× 130 1.4× 131 1.6× 60 1.1× 36 495
Alexander Y. Hui United States 4 143 0.8× 247 1.9× 110 1.2× 182 2.2× 56 1.0× 6 513
Bach Quang Le Singapore 11 183 1.0× 41 0.3× 83 0.9× 87 1.1× 72 1.3× 23 372
Aline Lueckgen United States 6 225 1.2× 70 0.6× 134 1.4× 83 1.0× 51 0.9× 7 410
Saba Abdulghani Portugal 9 178 1.0× 47 0.4× 91 1.0× 128 1.6× 61 1.1× 19 413

Countries citing papers authored by Liangbin Zhou

Since Specialization
Citations

This map shows the geographic impact of Liangbin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangbin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangbin Zhou more than expected).

Fields of papers citing papers by Liangbin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangbin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangbin Zhou. The network helps show where Liangbin Zhou may publish in the future.

Co-authorship network of co-authors of Liangbin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Liangbin Zhou. A scholar is included among the top collaborators of Liangbin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangbin Zhou. Liangbin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhou, Liangbin, et al.. (2025). Embracing human relevance: The FDA’s historic move beyond animal testing mandates. 1(2). 9410013–9410013. 1 indexed citations
2.
Xu, Shunxiang, Hongwei Shao, Liangbin Zhou, et al.. (2025). Magnesium Silicate Composite Patch With Neurovascular Regenerative Properties Promotes Diabetic Wound Healing in Mice. SHILAP Revista de lepidopterología. 4(5). 745–762.
3.
Wang, Yuwen, Liangbin Zhou, Ye Chen, et al.. (2025). Multiscale metal-based nanocomposites for bone and joint disease therapies. Materials Today Bio. 32. 101773–101773. 2 indexed citations
4.
Du, Chengcheng, Jinping Chen, Liangbin Zhou, et al.. (2025). Cartilage-targeted drug delivery in osteoarthritis: Redefining local therapy with intelligent hydrogel microspheres. 3(4). 100160–100160. 1 indexed citations
5.
6.
Du, Chengcheng, Jiacheng Liu, Zhenglin Zhu, et al.. (2025). The role of 3D printing in skeletal muscle-on-a-chip models: Current applications and future potential. Materials Today Bio. 34. 102222–102222. 1 indexed citations
7.
Wang, Renheng, et al.. (2025). Wearable device–measured physical activity and risk of MAFLD in adolescents. American Journal of Preventive Cardiology. 24. 101345–101345.
8.
Zhou, Liangbin, Jingjing Huang, Cun Li, et al.. (2025). Organoids and organs-on-chips: Recent advances, applications in drug development, and regulatory challenges. Med. 6(4). 100667–100667. 20 indexed citations
9.
Luo, Xianshu, et al.. (2025). Precision and customization in regenerative medicine: The role of coaxial 3D printing. 12. 100115–100115. 1 indexed citations
10.
Chen, Ziyi, Jiankun Xu, Peijie Hu, et al.. (2025). Defective Cystic Fibrosis Transmembrane Conductance Regulator Accelerates Skeletal Muscle Aging by Impairing Autophagy/Myogenesis. Journal of Cachexia Sarcopenia and Muscle. 16(1). e13708–e13708. 2 indexed citations
11.
Du, Chengcheng, Jingdi Zhan, Zhuolin Chen, et al.. (2025). Emerging Trends in Injectable Stimuli‐Responsive Hydrogel Microspheres: Design Strategies and Therapeutic Innovations. SHILAP Revista de lepidopterología. 4(2). 3 indexed citations
12.
Wang, Xiaokang, Xianjing Hu, Chunxiao Ye, et al.. (2024). Astragalus Polysaccharide Enhances Voriconazole Metabolism under Inflammatory Conditions through the Gut Microbiota. Journal of Clinical and Translational Hepatology. 12(5). 481–495. 10 indexed citations
13.
Zhou, Liangbin, Kevin Ki‐Wai Ho, Lizhen Zheng, et al.. (2024). A rabbit osteochondral defect (OCD) model for evaluation of tissue engineered implants on their biosafety and efficacy in osteochondral repair. Frontiers in Bioengineering and Biotechnology. 12. 1352023–1352023. 1 indexed citations
14.
Zhou, Liangbin, A. Schwab, Wenxue Tong, et al.. (2023). Engineered biochemical cues of regenerative biomaterials to enhance endogenous stem/progenitor cells (ESPCs)-mediated articular cartilage repair. Bioactive Materials. 26. 490–512. 31 indexed citations
15.
Zou, Li, Xuan He, Ye Li, et al.. (2023). Hybrid Therapeutic Device (CUHK-OA-M2) for Relieving Symptoms Induced by Knee Osteoarthritis. Bioengineering. 10(1). 95–95. 2 indexed citations
16.
Ye, Xiangdong, Huajun Zhang, Xudong Luo, et al.. (2023). Characterization of the Hemolytic Activity of Mastoparan Family Peptides from Wasp Venoms. Toxins. 15(10). 591–591. 7 indexed citations
17.
Zhou, Liangbin, Peng Guo, Matteo D’Este, et al.. (2022). Functionalized Hydrogels for Articular Cartilage Tissue Engineering. Engineering. 13. 71–90. 59 indexed citations
18.
Li, Ye, Jiankun Xu, Jie Mi, et al.. (2021). Biodegradable magnesium combined with distraction osteogenesis synergistically stimulates bone tissue regeneration via CGRP-FAK-VEGF signaling axis. Biomaterials. 275. 120984–120984. 131 indexed citations
19.
Zhou, Liangbin, Jos Malda, Martin J. Stoddart, et al.. (2020). Innovative Tissue‐Engineered Strategies for Osteochondral Defect Repair and Regeneration: Current Progress and Challenges. Advanced Healthcare Materials. 9(23). e2001008–e2001008. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026